Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.66 |
| ▸ | RAB9A | P51151 | 3/20 | 0.66 |
| ▸ | CA12 | O43570 | 2/20 | 0.66 |
| ▸ | CA9 | Q16790 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | MGLL | Q99685 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL180384 | 0.85 | NPC1 (0.73) | NPC1RAB9ACA12CA9KMT2A | |
| SCHEMBL3095761 | 0.83 | NPC1 (0.70) | NPC1RAB9ACA12CA9KMT2A | |
| Hydrochloric Acid SCHEMBL11786759 | 0.83 | NPC1 (0.70) | NPC1RAB9ACA12CA9KMT2A | |
| SCHEMBL544271 | 0.82 | NPC1 (0.75) | NPC1RAB9ACA12CA9KMT2A | |
| SCHEMBL967363 | 0.81 | NPC1 (0.68) | NPC1RAB9ACA12CA9KMT2A | |
| SCHEMBL425164 | 0.81 | NPC1 (0.68) | NPC1RAB9ACA12CA9KMT2A | |
| SCHEMBL21592416 | 0.80 | KMT2A (0.49) | NPC1RAB9ACA12CA9KMT2A | |
| SCHEMBL4939224 | 0.80 | RAB9A (0.72) | NPC1RAB9ACA12CA9KMT2A | |
| SCHEMBL13134912 | 0.79 | NPC1 (0.66) | NPC1RAB9ACA12CA9KMT2A | |
| SCHEMBL3369887 | 0.79 | NPC1 (0.66) | NPC1RAB9ACA12CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130121953-A1 | COMPOSITIONS | MICRODERMIS CORPORATION (US) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130121953-A1 | COMPOSITIONS | POLE3, POLR1C, SSTR3 | NPC1 2610/4885RAB9A 312/4885CA12 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.